Edition:
India

Phase 3 Randomized Trial Data Shows SBRT Has Similar Acute Safety Profile To Conventional Radiation Therapy In Patients With Localized Prostate Cancer


Friday, 22 Feb 2019 

Feb 22 (Reuters) - Accuray Inc ::PHASE 3 RANDOMIZED TRIAL DATA SHOWS SBRT HAS SIMILAR ACUTE SAFETY PROFILE TO CONVENTIONAL RADIATION THERAPY IN PATIENTS WITH LOCALIZED PROSTATE CANCER.DESPITE HIGH DOSE, USE OF SBRT & CONVENTIONAL RADIATION THERAPY RESULT IN COMPARABLE RATES OF ACUTE GASTROINTESTINAL,GENITOURINARY TOXICITY. 

Company Quote

3.22
0.0 +0.00%
10:04pm IST